India  

India's first COVID-19 vaccine candidate cleared for human trials

Al Jazeera Tuesday, 30 June 2020
Drug Controller General of India approves Bharat Biotech's Covaxin for clinical human trials which will start in July.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Russia approves Covid-19 vaccine 'Sputnik V': Why's the world sceptical? [Video]

Russia approves Covid-19 vaccine 'Sputnik V': Why's the world sceptical?

Russia has become the first country to approve a Covid-19 vaccine and it has been named 'Sputnik V'. Russian President Vladimir Putin said that the vaccine was effective and said that one of his..

Credit: HT Digital Content     Duration: 03:03Published
Covid vaccine: Why India won't take Russia's Sputnik V right now | Oneindia News [Video]

Covid vaccine: Why India won't take Russia's Sputnik V right now | Oneindia News

Russia claims that many countries have placed an order for the world's 'first' Covid vaccine that it has developed. But, it is unlikely that this vaccine will be made available in India. For this 2..

Credit: Oneindia     Duration: 01:28Published
Covid update: India vaccine progress; another minister infected; IMF on economy [Video]

Covid update: India vaccine progress; another minister infected; IMF on economy

From another minister in the Narendra Modi cabinet testing positive for infection, to the progress report of India's indigenously-developed vaccine candidates - here are the top news updates on the..

Credit: HT Digital Content     Duration: 02:41Published

Related news from verified sources

India’s first Covid-19 vaccine candidate by Hyderabad-based Bharat Biotech set for trials

India’s first Covid-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology (NIV),...
IndiaTimes


Tweets about this